BioSpace News Archive

I-Mab Receives IND Approval from the US FDA to Initiate Clinical Trials for Its Proprietary TJC4, a Potential Global Best-in-Class Anti-CD47 Monoclonal Antibody

I-Mab Biopharma (“I-Mab”), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, announces on Jan. 25, 2019 that its IND application for TJC4, has been approved by the US Food & Drug Administration (FDA).

January 28, 2019
·
3 min read
Drug Development

NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children’s

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children’s Hospital Medical Center in the United States.

January 28, 2019
·
3 min read
BioMidwest

Upsher-Smith Celebrates A Century Of Serving Patients

Pharmaceutical Company Highlights Past Achievements, Future Endeavors

January 28, 2019
·
2 min read
Business

The 2019 Co-located Phacilitate Leaders World & World Stem Cell Summit in Miami Solidified Regenerative Medicine as the Future of Healthcare

The international regenerative medicine community concluded a week of sharing breakthroughs, facing challenges and developing collaborations at the 2019 co-locatedPhacilitate Leaders World and World Stem Cell Summit (WSCS) at the Hyatt Regency Miami, January 22-25, 2019.

January 28, 2019
·
7 min read
Futura Medical to Present on new Impedance Testing Data for MED2005 for the Treatment of Erectile Dysfunction at the 21st ESSM Congress and Host Advisory Meeting

Futura Medical plc (AIM: FUM) (the “Company”), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, today announces that it will be presenting safety data in female partners on its lead product MED2005,

January 28, 2019
·
5 min read
Growing Prevalence of Dementia Expected to Propel the Demand for Frontotemporal Disorders Treatment Drugs Market

With the severe dearth of FDA-approved drugs in the reliable treatment of frontotemporal disorders, frontotemporal disorders treatment continues to underscore the growing significance of disease management

January 28, 2019
·
5 min read
Neuropathic Pain Market: lucrative opportunities and Fast Growth by 2026

According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024).

January 28, 2019
·
3 min read
Business

Colorado Springs Infertility Practice’s Reduced Fees Spotlighted by Wall Street Journal

A Colorado Springs infertility specialist highlighted by the Wall Street Journal for his low fee structure is calling on peers to offer lower prices and be transparent about their fees.

January 28, 2019
·
2 min read
Pharm Country

Measles-Mumps-Rubella Vaccine Available at Rite Aid Pharmacies in Washington State and Oregon

With an increase in measles cases being reported in the region, Rite Aid announced today that Measles-Mumps-Rubella (MMR) vaccinations are available upon request at Rite Aid pharmacies in Washington state and Oregon.

January 28, 2019
·
2 min read
Business

Pulse Biosciences to Report Fourth Quarter and Full Year 2018 Operational Highlights and Financial Results

Pulse Biosciences, Inc. today announced that the Company will report fourth-quarter and full-year 2018 operational highlights and financial results on Thursday, February 7, 2019.

January 28, 2019
·
2 min read